search
Back to results

Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea (APNiA)

Primary Purpose

Obstructive Sleep Apnea (OSA)

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Home Respiratory Polygraphy (APNIA)
Standard Polysomnography (PSG)
Home Respiratory Polygraphy (APNIA)
Standard Polysomnography (PSG)
Sponsored by
Hospital Universitario Araba
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Obstructive Sleep Apnea (OSA) focused on measuring Home Respiratory Polygraphy, Standard Polysomnography, Validity, Cost-effectiveness

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Men and women over 18 years to 75 years old, with clinical suspicion of OSA
  • Written informed consent signed

Exclusion Criteria:

  • Psycho-Physical inability to perform the study at home
  • Presence of insomnia or depressive syndrome
  • Patient with malformation syndromes, Down syndrome and neuromuscular diseases
  • Cardiovascular, cerebrovascular or respiratory disease exacerbated.
  • Previous Positive continuous pressure (CPAP ) treatment or surgery for OSA

Sites / Locations

  • Hospital Universitario Araba

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Diagnostic Randomizing

Therapeutic Randomizing

Arm Description

Randomizing to start with home respiratory polygraphy (APNIA) or Standard Polysomnography (PSG)

Randomizing for therapeutic decision taken with home respiratory polygraphy (APNIA) or Standard Polysomnography (PSG)

Outcomes

Primary Outcome Measures

Apnea-Hypopnea Index (AHI)
To assess the diagnostic validity of a home respiratory polygraphy (HRP) compared with the standard polysomnography (PSG) in adults with clinically suspected Obstructive Sleep Apnea (OSA), based on the results of the Apnea-hypopnea Index (AHI).

Secondary Outcome Measures

Therapeutic decision
The concordance of the diagnosis and treatment decision when using clinical findings and data from standard polysomnography (PSG) or home respiratory polygraphy (HRP).
Epworth Sleepiness Scale
The Epworth Sleepiness Scale (the sum of 8 items score,0-3) can range from 0 to 24. Scores of 11-24 represent increasing levels of excessive daytime sleepiness.
STOP-BANG Sleep apnea questionnaire
Sleep Apnea Questionnaire. High STOP-Bang score indicates a high probability of obstructive sleep apnea.
Berlin questionnaire
The questionnaire consists of 3 categories related to the risk of having sleep apnea. Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories. High Risk: if there are 2 or more categories where the score is positive. Low Risk: if there is only 1 or no categories where the score is positive.
Cost-effectiveness analysis
Cost-efficacy evaluation
Blood pressure
Blood pressure measurements: systolic blood pressure and diastolic blood pressure
Anthropometric variables (Body mass index)
Body mass index
Quality of life (EuroQOL test)
Evaluate by EuroQOL test, is a standardised measure of health status. Description of the state of health in five dimensions (mobility, self-car, usual activities, pain/discomfort and anxiety/depression), each o wich is defined with three levels of severity, as measured by a Likert scale type (no problems, some problems and many problems or inability to activity).

Full Information

First Posted
September 30, 2016
Last Updated
September 5, 2018
Sponsor
Hospital Universitario Araba
Collaborators
BTI Biotechnology Institute S.L, Instituto de Investigación Sanitaria BIO-ARABA
search

1. Study Identification

Unique Protocol Identification Number
NCT03415633
Brief Title
Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea
Acronym
APNiA
Official Title
Validity and Cost-effectiveness Analysis of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
September 2015 (undefined)
Primary Completion Date
June 2018 (Actual)
Study Completion Date
September 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Universitario Araba
Collaborators
BTI Biotechnology Institute S.L, Instituto de Investigación Sanitaria BIO-ARABA

4. Oversight

5. Study Description

Brief Summary
To assess the diagnostic validity and cost-effectiveness of a APNiA device, a home respiratory polygraphy (HRP).
Detailed Description
To assess the diagnostic validity and cost-effectiveness of a APNiA device, a home respiratory polygraphy (HRP), performed at home compared with the standard polysomnography (PSG) in adults with clinically suspected Obstructive Sleep Apnea (OSA). METHODOLOGY: DESIGN: Randomized, prospective, multicenter, and crossover trial. The study will include 240 adults, both sexes, with clinical suspicion of obstructive sleep apnea (OSA). MEASUREMENTS: To all patients with clinical suspected OSA and referred to the sleep units, the following questionnaires and measurements will be performed: a) clinical history; b) Anthropometric variables: weight, height, body mass index, neck circumference and percentile; c)Epworth sleepiness scale; OSA questionnaire, quality of life and clinical questionnaires and comorbidity; d) PSG in the sleep laboratory; e) HRP at home; f) Cost-effectiveness variables. ANALYSIS: Data from HRP and from full PSG will be compared as follows: 1) Agreement of results according to the different apnea-hypopnea index by using the Receiver Operating Characteristic (ROC) curve; 2) The concordance of the diagnosis and treatment decisions when using clinical findings and data from PSG or HRP at home; 3) All data will be analyzed independently; 4) A cost-effectiveness analysis of the different diagnostic and therapeutic procedures will be performed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Sleep Apnea (OSA)
Keywords
Home Respiratory Polygraphy, Standard Polysomnography, Validity, Cost-effectiveness

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
251 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diagnostic Randomizing
Arm Type
Active Comparator
Arm Description
Randomizing to start with home respiratory polygraphy (APNIA) or Standard Polysomnography (PSG)
Arm Title
Therapeutic Randomizing
Arm Type
Active Comparator
Arm Description
Randomizing for therapeutic decision taken with home respiratory polygraphy (APNIA) or Standard Polysomnography (PSG)
Intervention Type
Other
Intervention Name(s)
Home Respiratory Polygraphy (APNIA)
Other Intervention Name(s)
Validity
Intervention Description
Randomizing to start with home respiratory polygraphy (APNIA)
Intervention Type
Other
Intervention Name(s)
Standard Polysomnography (PSG)
Other Intervention Name(s)
Validity
Intervention Description
Randomizing to start with Standard Polysomnography (PSG)
Intervention Type
Other
Intervention Name(s)
Home Respiratory Polygraphy (APNIA)
Other Intervention Name(s)
Effectiveness
Intervention Description
Randomizing for therapeutic decision taken with home respiratory polygraphy (APNIA)
Intervention Type
Other
Intervention Name(s)
Standard Polysomnography (PSG)
Other Intervention Name(s)
Effectiveness
Intervention Description
Randomizing for therapeutic decision taken with Standard Polysomnography (PSG)
Primary Outcome Measure Information:
Title
Apnea-Hypopnea Index (AHI)
Description
To assess the diagnostic validity of a home respiratory polygraphy (HRP) compared with the standard polysomnography (PSG) in adults with clinically suspected Obstructive Sleep Apnea (OSA), based on the results of the Apnea-hypopnea Index (AHI).
Time Frame
baseline
Secondary Outcome Measure Information:
Title
Therapeutic decision
Description
The concordance of the diagnosis and treatment decision when using clinical findings and data from standard polysomnography (PSG) or home respiratory polygraphy (HRP).
Time Frame
6 month
Title
Epworth Sleepiness Scale
Description
The Epworth Sleepiness Scale (the sum of 8 items score,0-3) can range from 0 to 24. Scores of 11-24 represent increasing levels of excessive daytime sleepiness.
Time Frame
baseline and at 6 month
Title
STOP-BANG Sleep apnea questionnaire
Description
Sleep Apnea Questionnaire. High STOP-Bang score indicates a high probability of obstructive sleep apnea.
Time Frame
baseline and at 6 month
Title
Berlin questionnaire
Description
The questionnaire consists of 3 categories related to the risk of having sleep apnea. Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories. High Risk: if there are 2 or more categories where the score is positive. Low Risk: if there is only 1 or no categories where the score is positive.
Time Frame
baseline and at 6 month
Title
Cost-effectiveness analysis
Description
Cost-efficacy evaluation
Time Frame
6 month
Title
Blood pressure
Description
Blood pressure measurements: systolic blood pressure and diastolic blood pressure
Time Frame
baseline and at 6 month
Title
Anthropometric variables (Body mass index)
Description
Body mass index
Time Frame
baseline and at 6 month
Title
Quality of life (EuroQOL test)
Description
Evaluate by EuroQOL test, is a standardised measure of health status. Description of the state of health in five dimensions (mobility, self-car, usual activities, pain/discomfort and anxiety/depression), each o wich is defined with three levels of severity, as measured by a Likert scale type (no problems, some problems and many problems or inability to activity).
Time Frame
baseline and at 6 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women over 18 years to 75 years old, with clinical suspicion of OSA Written informed consent signed Exclusion Criteria: Psycho-Physical inability to perform the study at home Presence of insomnia or depressive syndrome Patient with malformation syndromes, Down syndrome and neuromuscular diseases Cardiovascular, cerebrovascular or respiratory disease exacerbated. Previous Positive continuous pressure (CPAP ) treatment or surgery for OSA
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joaquin Duran-Cantolla
Organizational Affiliation
Hospital Universitario Araba
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Eduardo Anitua-Aldecoa
Organizational Affiliation
BTI Technology Institute SL
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario Araba
City
Gasteiz / Vitoria
State/Province
Araba
ZIP/Postal Code
01009
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
Citation
1. Durán-Cantolla J, Puertas FJ, Pin G y el Grupo Español de Sueño (GES).Documento de consenso nacional sobre el SAHS. Arch Bronconumol 2005;41(nº4):1-110.
Results Reference
background
PubMed Identifier
21398016
Citation
Lloberes P, Duran-Cantolla J, Martinez-Garcia MA, Marin JM, Ferrer A, Corral J, Masa JF, Parra O, Alonso-Alvarez ML, Teran-Santos J. Diagnosis and treatment of sleep apnea-hypopnea syndrome. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol. 2011 Mar;47(3):143-56. doi: 10.1016/j.arbres.2011.01.001. No abstract available. Erratum In: Arch Bronconeumol. 2011 Jul;47(7):378. English, Spanish.
Results Reference
background
PubMed Identifier
19688045
Citation
Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, Rapoport DM, Redline S, Resnick HE, Robbins JA, Shahar E, Unruh ML, Samet JM. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009 Aug;6(8):e1000132. doi: 10.1371/journal.pmed.1000132. Epub 2009 Aug 18.
Results Reference
background
PubMed Identifier
7952834
Citation
Duran Cantolla J, Esnaola Sukia S, Rubio Aramendi R, Egea Santaolalla C. [Validity of a portable recording system (MESAM IV) for the diagnosis of sleep apnea syndrome]. Arch Bronconeumol. 1994 Aug-Sep;30(7):331-8. Spanish.
Results Reference
background
PubMed Identifier
8980975
Citation
Esnaola S, Duran J, Infante-Rivard C, Rubio R, Fernandez A. Diagnostic accuracy of a portable recording device (MESAM IV) in suspected obstructive sleep apnoea. Eur Respir J. 1996 Dec;9(12):2597-605. doi: 10.1183/09031936.96.09122597.
Results Reference
background
PubMed Identifier
9272909
Citation
Parra O, Garcia-Esclasans N, Montserrat JM, Garcia Eroles L, Ruiz J, Lopez JA, Guerra JM, Sopena JJ. Should patients with sleep apnoea/hypopnoea syndrome be diagnosed and managed on the basis of home sleep studies? Eur Respir J. 1997 Aug;10(8):1720-4. doi: 10.1183/09031936.97.10081720.
Results Reference
background
PubMed Identifier
10726178
Citation
Jimenez Gomez A, Golpe Gomez R, Carpizo Alfayate R, de la Roza Fernandez C, Fernandez Rozas S, Garcia Perez MM. [The validation of a portable 3-channel recording system (Oxyflow, Edentec) for the diagnosis of the sleep apnea syndrome]. Arch Bronconeumol. 2000 Jan;36(1):7-12. doi: 10.1016/s0300-2896(15)30226-x. Spanish.
Results Reference
background
PubMed Identifier
12503711
Citation
Calleja JM, Esnaola S, Rubio R, Duran J. Comparison of a cardiorespiratory device versus polysomnography for diagnosis of sleep apnoea. Eur Respir J. 2002 Dec;20(6):1505-10. doi: 10.1183/09031936.02.00297402.
Results Reference
background
PubMed Identifier
14636489
Citation
Nunez R, Rey de Castro J, Socarras E, Calleja JM, Rubio R, Aizpuru F, Duran-Cantolla J. [Validation study of a polygraphic screening device (BREAS SC20) in the diagnosis of sleep apnea-hypopnea syndrome]. Arch Bronconeumol. 2003 Dec;39(12):537-43. doi: 10.1016/s0300-2896(03)75451-9. Spanish.
Results Reference
background
PubMed Identifier
21602541
Citation
Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hernandez-Blasco L, Monasterio C, Alonso A, Chiner E, Rubio M, Garcia-Ledesma E, Cacelo L, Carpizo R, Sacristan L, Salord N, Carrera M, Sancho-Chust JN, Embid C, Vazquez-Polo FJ, Negrin MA, Montserrat JM. Effectiveness of home respiratory polygraphy for the diagnosis of sleep apnoea and hypopnoea syndrome. Thorax. 2011 Jul;66(7):567-73. doi: 10.1136/thx.2010.152272. Epub 2011 May 20.
Results Reference
background
PubMed Identifier
21737584
Citation
Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hernandez-Blasco L, Monasterio C, Alonso A, Chiner E, Zamorano J, Aizpuru F, Montserrat JM; Spanish Sleep Network. Therapeutic decision-making for sleep apnea and hypopnea syndrome using home respiratory polygraphy: a large multicentric study. Am J Respir Crit Care Med. 2011 Oct 15;184(8):964-71. doi: 10.1164/rccm.201103-0428OC. Epub 2011 Jul 7. Erratum In: Am J Respir Crit Care Med. 2012 Jan 15;185(2):233.
Results Reference
background
PubMed Identifier
16171294
Citation
Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005 Apr;28(4):499-521. doi: 10.1093/sleep/28.4.499.
Results Reference
background
PubMed Identifier
8520819
Citation
Duran Cantolla J, Amilibia Alonso J, Barbe Illa F, Capote Gil F, Gonzalez-Mangado N, Jimenez Gomez A, Marin Trigo JM, Masa Jimenez JF, Montserrat Canal JM, Teran Santos J. [Availability of technical resources for diagnosis and treatment of sleep obstructive apnea syndrome in state hospitals in Spain]. Arch Bronconeumol. 1995 Nov;31(9):463-9. No abstract available. Spanish.
Results Reference
background
PubMed Identifier
8417909
Citation
Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest. 1993 Jan;103(1):30-6. doi: 10.1378/chest.103.1.30.
Results Reference
background
PubMed Identifier
18431116
Citation
Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, Khajehdehi A, Shapiro CM. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008 May;108(5):812-21. doi: 10.1097/ALN.0b013e31816d83e4.
Results Reference
background
PubMed Identifier
10507956
Citation
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999 Oct 5;131(7):485-91. doi: 10.7326/0003-4819-131-7-199910050-00002.
Results Reference
background
PubMed Identifier
19714380
Citation
Ragette R, Wang Y, Weinreich G, Teschler H. Diagnostic performance of single airflow channel recording (ApneaLink) in home diagnosis of sleep apnea. Sleep Breath. 2010 Jun;14(2):109-14. doi: 10.1007/s11325-009-0290-2. Epub 2009 Aug 28.
Results Reference
background

Learn more about this trial

Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea

We'll reach out to this number within 24 hrs